Skip to main content

Table 1 Baseline characteristics of the study participants with and without albuminuria*

From: Predictors of microalbuminuria and its relationship with glycemic control among Type 2 diabetic patients of Jazan Armed Forces Hospital, southwestern Saudi Arabia

 

Control

group

Microalbuminuria cases ▲▲

Macroalbuminuria cases**

Age in years

53.5 (12.3)

55.1 (13.6)

54.7 (13.8)

Duration of diabetes (years)

7.6 (7.2)

7.7 (7.1)

6.4 (6.2)

HbA1c (%)

8.4 (1.9)

9.3 (2.2) ▲, ♣

10.5 (2.3) ▲, ♣

TC (mg/dL)

183.0 (40.3)

183.7 (44.2)

191.2 (45.0)

LDL (mg/dL)

114.0 (38.5)

115.5 (43.2)

121.0 (46.4)

HDL (mg/dL)

45.3 (11.5)

46.4 (12.9)

47.8 (13.5)

Tg (mg/dL)

144.9 (74.3)

136.6 (64.5)

139.1 (74.1)

eGFR (mL/min/1.73)

102.2 (21.3)

94.1 (22.9) ▲,♣

78.9 (30.4) ▲, ♣

BMI (kg/m2)®®

30.6 (5.9)

32.4® (6.7)

27.8 (2.1)

  1. , Control group with normal urine ACR, n, 202; ▲▲, Microalbuminuria (cases, n, 202) with ACR: 30–300;**, Macroalbuminuria, n,30, with ACR˃300;*, mean and standard deviation in parentheses; , The control group is significantly different from the other two groups; , microalbuminuria is significantly different from the macroalbuminuria group; ®, Microalbuminuria is significantly different from the control and macroalbuminuria groups; HbA1c, glycosylated hemoglobin; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; and eGFR, estimated glomerular filtration rate; ®®, body mass index in kg/m2x